- Home
- PED vs CUE Comparison
PED vs CUE Comparison
Compare PED & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- CUE
- Stock Information
- Founded
- PED N/A
- CUE 2014
- Country
- PED United States
- CUE United States
- Employees
- PED N/A
- CUE N/A
- Industry
- PED Oil & Gas Production
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- CUE Health Care
- Exchange
- PED Nasdaq
- CUE Nasdaq
- Market Cap
- PED 48.8M
- CUE 57.7M
- IPO Year
- PED N/A
- CUE 2018
- Fundamental
- Price
- PED $0.65
- CUE $0.75
- Analyst Decision
- PED Strong Buy
- CUE Strong Buy
- Analyst Count
- PED 1
- CUE 3
- Target Price
- PED $1.50
- CUE $3.00
- AVG Volume (30 Days)
- PED 124.9K
- CUE 515.6K
- Earning Date
- PED 08-13-2025
- CUE 08-13-2025
- Dividend Yield
- PED N/A
- CUE N/A
- EPS Growth
- PED 2248.88
- CUE N/A
- EPS
- PED 0.19
- CUE N/A
- Revenue
- PED $40,173,000.00
- CUE $7,991,000.00
- Revenue This Year
- PED N/A
- CUE N/A
- Revenue Next Year
- PED $5.99
- CUE $23.84
- P/E Ratio
- PED $3.50
- CUE N/A
- Revenue Growth
- PED 30.70
- CUE 13.83
- 52 Week Low
- PED $0.47
- CUE $0.45
- 52 Week High
- PED $1.07
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- PED 51.19
- CUE 45.03
- Support Level
- PED $0.62
- CUE $0.84
- Resistance Level
- PED $0.69
- CUE $0.90
- Average True Range (ATR)
- PED 0.03
- CUE 0.10
- MACD
- PED 0.00
- CUE -0.01
- Stochastic Oscillator
- PED 43.00
- CUE 15.33
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.